G. S. Crowther

813 total citations
26 papers, 672 citations indexed

About

G. S. Crowther is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, G. S. Crowther has authored 26 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 16 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in G. S. Crowther's work include Clostridium difficile and Clostridium perfringens research (22 papers), Microscopic Colitis (16 papers) and Helicobacter pylori-related gastroenterology studies (7 papers). G. S. Crowther is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (22 papers), Microscopic Colitis (16 papers) and Helicobacter pylori-related gastroenterology studies (7 papers). G. S. Crowther collaborates with scholars based in United Kingdom, Switzerland and India. G. S. Crowther's co-authors include C. H. Chilton, Jane Freeman, S. L. Todhunter, Mark H. Wilcox, Simon D. Baines, M. H. Wilcox, Scott Nicholson, Christopher Longshaw, Mark Wilcox and Richard Vickers and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

G. S. Crowther

26 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. S. Crowther United Kingdom	16	491	292	219	128	93	26	672
S. L. Todhunter United Kingdom	14	605 1.2×	357 1.2×	182 0.8×	139 1.1×	113 1.2×	17	702
C. H. Chilton United Kingdom	17	643 1.3×	333 1.1×	281 1.3×	149 1.2×	120 1.3×	42	804
Eugénie Bassères United States	14	257 0.5×	151 0.5×	168 0.8×	61 0.5×	54 0.6×	27	455
Ingrid M. J. G. Sanders Netherlands	18	681 1.4×	362 1.2×	276 1.3×	165 1.3×	71 0.8×	36	897
M. Sánchez-Somolinos Spain	8	606 1.2×	473 1.6×	151 0.7×	194 1.5×	76 0.8×	9	916
Liza Miller United States	6	365 0.7×	172 0.6×	354 1.6×	40 0.3×	28 0.3×	6	601
Padman Jayaratne Canada	14	565 1.2×	299 1.0×	388 1.8×	148 1.2×	31 0.3×	25	891
J Symonds United Kingdom	8	357 0.7×	174 0.6×	85 0.4×	57 0.4×	40 0.4×	15	546
Brian Kullin South Africa	14	404 0.8×	192 0.7×	161 0.7×	98 0.8×	53 0.6×	22	554
Rémi Le Guern France	14	183 0.4×	134 0.5×	144 0.7×	71 0.6×	28 0.3×	34	503

Countries citing papers authored by G. S. Crowther

Since Specialization

Citations

This map shows the geographic impact of G. S. Crowther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. S. Crowther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. S. Crowther more than expected).

Fields of papers citing papers by G. S. Crowther

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. S. Crowther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. S. Crowther. The network helps show where G. S. Crowther may publish in the future.

Co-authorship network of co-authors of G. S. Crowther

This figure shows the co-authorship network connecting the top 25 collaborators of G. S. Crowther. A scholar is included among the top collaborators of G. S. Crowther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. S. Crowther. G. S. Crowther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crowther, G. S., et al.. (2021). Efficacy of Topical Vancomycin- and Gentamicin-Loaded Calcium Sulfate Beads or Systemic Antibiotics in Eradicating Polymicrobial Biofilms Isolated from Diabetic Foot Infections within an In Vitro Wound Model. Antimicrobial Agents and Chemotherapy. 65(6). 7 indexed citations

Crowther, G. S., Sanhita Roy, Prashant Garg, et al.. (2020). Corneal Infection Models: Tools to Investigate the Role of Biofilms in Bacterial Keratitis. Cells. 9(11). 2450–2450. 50 indexed citations

Saubade, Fabien, Nina Dempsey‐Hibbert, G. S. Crowther, et al.. (2018). Effectiveness of titanium nitride silver coatings against Staphylococcus spp. in the presence of BSA and whole blood conditioning agents. International Biodeterioration & Biodegradation. 141. 44–51. 8 indexed citations

Chilton, C. H., G. S. Crowther, Helen Ashwin, Christopher Longshaw, & Mark H. Wilcox. (2016). Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production. PLoS ONE. 11(8). e0161200–e0161200. 27 indexed citations

Chilton, C. H., G. S. Crowther, Klaudyna Śpiewak, et al.. (2016). Potential of lactoferrin to prevent antibiotic-inducedClostridium difficileinfection. Journal of Antimicrobial Chemotherapy. 71(4). 975–985. 24 indexed citations

Crowther, G. S., Mark H. Wilcox, & C. H. Chilton. (2016). An In Vitro Model of the Human Colon: Studies of Intestinal Biofilms and Clostridium difficile Infection. Methods in molecular biology. 1476. 223–234. 13 indexed citations

Chilton, C. H., G. S. Crowther, S. L. Todhunter, et al.. (2015). Efficacy of alternative fidaxomicin dosing regimens for treatment of simulatedClostridium difficileinfection in anin vitrohuman gut model. Journal of Antimicrobial Chemotherapy. 70(9). 2598–2607. 23 indexed citations

Wilcox, Mark & G. S. Crowther. (2015). Antibiotic therapy and Clostridium difficile infection – primum non nocere – first do no harm. Infection and Drug Resistance. 8. 333–333. 23 indexed citations

Crowther, G. S., C. H. Chilton, S. L. Todhunter, et al.. (2014). Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model. Journal of Antimicrobial Chemotherapy. 69(8). 2137–2147. 35 indexed citations

10.

Baines, Simon D., G. S. Crowther, Jane Freeman, et al.. (2014). SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model. Journal of Antimicrobial Chemotherapy. 70(1). 182–189. 35 indexed citations

11.

Crowther, G. S., C. H. Chilton, S. L. Todhunter, et al.. (2014). Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota. PLoS ONE. 9(2). e88396–e88396. 39 indexed citations

12.

Baines, Simon D., G. S. Crowther, S. L. Todhunter, et al.. (2013). Mixed infection by Clostridium difficile in an in vitro model of the human gut. Journal of Antimicrobial Chemotherapy. 68(5). 1139–1143. 12 indexed citations

13.

Chilton, C. H., G. S. Crowther, Jane Freeman, et al.. (2013). Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure. Journal of Antimicrobial Chemotherapy. 69(2). 451–462. 41 indexed citations

14.

Chilton, C. H., Jane Freeman, Simon D. Baines, et al.. (2013). Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery. Journal of Antimicrobial Chemotherapy. 68(9). 2078–2082. 21 indexed citations

15.

Chilton, C. H., G. S. Crowther, Simon D. Baines, et al.. (2013). In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection. Journal of Antimicrobial Chemotherapy. 69(3). 697–705. 53 indexed citations

16.

Baines, Simon D., C. H. Chilton, G. S. Crowther, et al.. (2013). Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut model. Journal of Antimicrobial Chemotherapy. 68(8). 1842–1849. 15 indexed citations

17.

Chilton, C. H., Jane Freeman, G. S. Crowther, S. L. Todhunter, & Mark H. Wilcox. (2012). Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model. Journal of Antimicrobial Chemotherapy. 67(10). 2434–2437. 25 indexed citations

18.

Chilton, C. H., Jane Freeman, G. S. Crowther, et al.. (2012). Co-amoxiclav induces proliferation and cytotoxin production of Clostridium difficile ribotype 027 in a human gut model. Journal of Antimicrobial Chemotherapy. 67(4). 951–954. 24 indexed citations

19.

Crowther, G. S., Simon D. Baines, S. L. Todhunter, et al.. (2012). Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection. Journal of Antimicrobial Chemotherapy. 68(1). 168–176. 96 indexed citations

20.

Freeman, Jane, Miriam Marquis, G. S. Crowther, et al.. (2012). Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model. Journal of Antimicrobial Chemotherapy. 67(12). 2919–2926. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact